The ERA Registry Annual Report 2019: summary and age comparisons.
Rianne BoeninkMegan E AstleyJilske A HuijbenVianda S StelJulia KerschbaumMai Ots-RosenbergAnders A ÅsbergFrantisek LopotEliezer GolanPablo Castro de la NuezMarta Rodríguez CamblorSara Trujillo-AlemánJuan Carlos Ruiz San MillanPablo Ucio MingoJuan Manuel DíazM Encarnación Bouzas-CaamañoMarta ArtamendiManuel I Aparicio MadreCarmen Santiuste de PablosMaría Fernanda Slon RobleroOscar ZurriagaMaria E StendahlSamira BellAlma IdriziKyriakos IoannouAlicja Debska-SlizienAna A GalvãoJohan M De MeesterHalima ResićKristine HommelDanilo RadunovicRunolfur PálssonMathilde LassallePatrik FinneMaría De Los Ángeles-Garcia BazagaNikola GjorgjievskiNurhan SeyahiMarjolein BonthuisAlberto Ortiz ArduanKitty J JagerAnneke KramerPublished in: Clinical kidney journal (2021)
In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.